Tychan to Begin First Clinical Trials for First Novel Monoclonal Antibody Against COVID-19
Draws on Experience Developing Treatments for Yellow Fever and Zika in Accelerated Timeframe SINGAPORE--(BUSINESS WIRE)--Tychan, a Singapore-based clinical-stage biotechnology company,...






